You are here

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
PostScript
Letter
CBD diagnostic criteria: exclusions as important as inclusions
  1. Irene Litvan1,
  2. Anthony E Lang2,3,
  3. Melissa Armstrong4
  1. 1 Neuroscience Department, University of California San Diego, La Jolla, California, USA
  2. 2 Neurology, Toronto Western Hospital Krembil Neuroscience Centre, Toronto, Ontario, Canada
  3. 3 Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, University Health Network, Toronto, Ontario, Canada
  4. 4 Neurology Department, University of Florida, Gainesville, Florida, USA
  1. Correspondence to Dr Irene Litvan, Neuroscience Department, University of California San Diego, La Jolla, California, USA; ilitvan{at}ucsd.edu

http://dx.doi.org/10.1136/jnnp-2022-330564

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We enjoyed reading the publication by Koga et al on ‘Neuropathology and emerging biomarkers in corticobasal syndrome’1 but would like to clarify their statement that ‘subsequent clinicopathological studies have shown that the sensitivity and specificity of the Armstrong criteria are suboptimal’. It is critical to emphasise …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles